The PATHWAY HER2 (4B5) test is now FDA-approved to assess HER2-ultralow status in metastatic breast cancer, expanding its ...

Genentech Inc. won regulatory approval Tuesday to market an eye implant that can be refilled every six months with an already ...

The telehealth company Hims & Hers put out a Super Bowl ad that skimped on clarifying that its compounded semaglutide medications aren't FDA-approved.

BD affects millions but remains misunderstood, underdiagnosed, and underfunded. Researchers are working to change this by ...

FDA published a final version of its guidance document, “Communications From Firms to Health Care Providers Regarding ...

On January 7, 2025, the U.S. Food and Drug Administration (“FDA” or “Agency”) released a long-awaited guidance titled, “Communications From Firms ...

Librela (bedinvetmab injection) is a monthly injectable monoclonal antibody, for which real-world drug experience data has ...

Advocates say microdosing reduces costs and side effects while maintaining weight loss, then can help with weight maintenance ...

FDA Approves Symbravo for Acute Treatment of Migraine ... Finally, in the MOVEMENT long-term open-label safety trial (706 patients; treating at least two migraines per month), the long-term ...

Eli Lilly And Cao (NYSE:LLY) announced the results from the VIVID-2 open-label extension study of Omvoh (mirikizumab-mrkz).

Genentech has shared positive data from the Phase III REGENCY trial with regulators in the US and EU. Roche’s subsidiary ...

The Vivacity-MG3 study is currently in its open-label extension phase, which is investigating the longer-term safety and ...